These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11202807)

  • 1. Tissue polypeptide-specific antigen and carcinoembryonic antigen for early prediction of recurrence in lung adenocarcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Am J Clin Oncol; 2000 Dec; 23(6):605-8. PubMed ID: 11202807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma.
    Kao CH; Hsieh JF; Ho YJ; Ding HJ
    Lung; 1999; 177(5):333-7. PubMed ID: 10467024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma.
    Ho YJ; Hsieh JF; Tasi SC; Lee JK; Kao CH
    Lung; 2000; 178(2):75-80. PubMed ID: 10773133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
    Fernandes LC; Kim SB; Saad SS; Matos D
    World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
    Lee YC; Yang PC; Kuo SH; Luh KT
    J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
    Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
    Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
    Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
    Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection.
    Yeh JJ; Liu FY; Hsu WH; Wang JJ; Ho ST; Kao A
    Lung; 2002; 180(5):273-9. PubMed ID: 12489021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
    Nisman B; Amir G; Lafair J; Heching N; Lyass O; Peretz T; Barak V
    Anticancer Res; 1999; 19(4C):3549-52. PubMed ID: 10629651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
    Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer.
    Kashiwabara K; Saeki S; Sasaki J; Nomura M; Kohrogi H
    J Thorac Oncol; 2008 Dec; 3(12):1416-20. PubMed ID: 19057266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.
    Shoji F; Yoshino I; Yano T; Kometani T; Ohba T; Kouso H; Takenaka T; Miura N; Okazaki H; Maehara Y
    Cancer; 2007 Dec; 110(12):2793-8. PubMed ID: 17941001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial determinations of carcinoembryonic antigen for early detection of recurrent gastric cancer.
    Tamada R; Hiramoto Y; Abe Y; Nouzuka T; Okamura T; Masuda H; Kano T; Kumashiro R; Inokuchi K
    Jpn J Surg; 1982; 12(6):429-33. PubMed ID: 7166914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse.
    Vizcarra E; Lluch A; Cibrián R; Jarque F; García-Conde J
    Oncology; 1994; 51(6):491-6. PubMed ID: 7970492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
    Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
    Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.
    Bhatavdekar JM; Patel DD; Giri DD; Karelia NH; Vora HH; Ghosh N; Shah NG; Trivedi SN; Balar DB
    Br J Cancer; 1992 Nov; 66(5):977-80. PubMed ID: 1419646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
    Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Am J Clin Oncol; 2000 Jun; 23(3):241-3. PubMed ID: 10857885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1, TPS in the diagnosis of lung cancer].
    Huang F; Wang XL; Yang L; Yin BX; Geng Y; Li TT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):370-2. PubMed ID: 18394347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.